Find Your Funding Opportunity
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
04-11-2025 | $2.0 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 1
- Opportunity Type Discretionary
-
CFDA
93.110 -- Maternal and Child Health Federal Consolidated Programs
Description
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) program is to reduce morbidity and mortality associated with HHT by: 1) expanding access to and coordination of care for HHT patients; and 2) developing a de-identified, aggregate patient data registry to better understand this rare disease and treatment outcomes.
MCHB
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
Any domestic public or private entity, including an Indian tribe or tribal organization as those terms are defined in 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. Domestic faith-based and community-based organizations are eligible to apply.
Key Date(s)
- July 25, 2024: Forecasted Date
- August 28, 2024: Last Updated Date
- January 10, 2025: Estimated Post Date
- April 11, 2025: Estimated Application Due Date
- September 01, 2025: Estimated Project Start Date